Tech Company Financing Transactions
KIFFIK Biomedical Funding Round
KIFFIK Biomedical secured a Series A investment round on 12/18/2025. Investors included private investors.
Transaction Overview
Company Name
Announced On
12/18/2025
Transaction Type
Venture Equity
Amount
Unknown
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to support the expansion of its platform and advance five active clinical programs across oncology, neurology, and cardiometabolic disease.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Undisclosed
Miami, FL Undisclosed
USA
Miami, FL Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
KIFFIK sees a world where diagnostics are no longer reactive, but intuitive -- where listening to the body in real time becomes the foundation of preventive, personalized care for everyone. -- early, clearly, and without barriers. We envision a future where diagnostics are not confined to hospitals or triggered by symptoms, but integrated into daily life -- intuitive, non-invasive, and informed by the body's own intelligence. A future where real-time biomarker insights empower people to understand their health and act on it, long before conditions become crises.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
George Cagna
Browse more venture capital transactions:
Prev: 12/18/2025: HawkEye 360 venture capital transaction
Next: 12/18/2025: Exein venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here come from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs